How many institutions held SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in Q1 2015?

37 institutional investors reported SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share for Q1 2015. Use the holders table for investor-level position and value details.

SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)

Q: What does CUSIP P8696W104 represent in this 13F holders report?

CUSIP P8696W104 is the security identifier for SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share used to aggregate holder disclosures.

CUSIP: P8696W104

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class: Equity / Common Shares, par value US$0.001 per share
Shares outstanding: 71,872,133
Total 13F shares: 12,615,535
Share change: -264,000
Total reported value: $62,556,816
Price per share: $4.96
Number of holders: 37
Value change: -$1,441,431
Number of buys: 16
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2015
Previous quarter: Q4 2014

Recent filing periods for CUSIP P8696W104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	6.1%	4,389,060	$22,954,000	—	31 Dec 2014	13F
ORBIMED ADVISORS LLC	13F	Company	3.9%	2,821,500	$14,756,000	—	31 Dec 2014	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.6%	1,176,362	$6,152,000	—	31 Dec 2014	13F
Pine River Capital Management L.P.	13F	Company	1.5%	1,095,041	$5,727,000	—	31 Dec 2014	13F
FIL Ltd	13F	Company	1.5%	1,065,301	$5,572,000	—	31 Dec 2014	13F
BlackRock Fund Advisors	13F	Company	0.92%	661,735	$3,461,000	—	31 Dec 2014	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.43%	305,900	$1,600,000	—	31 Dec 2014	13F
DEUTSCHE BANK AG\	13F	Company	0.22%	157,925	$825,000	—	31 Dec 2014	13F
CITADEL ADVISORS LLC	13F	Company	0.22%	156,237	$817,000	—	31 Dec 2014	13F
Invesco Ltd.	13F	Company	0.2%	143,732	$752,000	—	31 Dec 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	130,123	$681,000	—	31 Dec 2014	13F
MORGAN STANLEY	13F	Company	0.16%	116,679	$610,000	—	31 Dec 2014	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.12%	84,888	$444,000	—	31 Dec 2014	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.11%	82,200	$430,000	—	31 Dec 2014	13F
Sensato Investors LLC	13F	Company	0.11%	75,772	$396,000	—	31 Dec 2014	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.11%	75,900	$367,000	—	31 Dec 2014	13F
Freedom Investment Management, Inc.	13F	Company	0.08%	56,519	$296,000	—	31 Dec 2014	13F
ProShare Advisors LLC	13F	Company	0.05%	36,802	$192,000	—	31 Dec 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	31,700	$166,000	—	31 Dec 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.03%	24,460	$128,000	—	31 Dec 2014	13F
CREDIT SUISSE AG/	13F	Company	0.03%	19,926	$104,000	—	31 Dec 2014	13F
ClariVest Asset Management LLC	13F	Company	0.03%	19,726	$103,000	—	31 Dec 2014	13F
STEVENS CAPITAL MANAGEMENT LP	13F	Company	0.02%	17,821	$93,000	—	31 Dec 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	17,025	$89,000	—	31 Dec 2014	13F
A.R.T. Advisors, LLC	13F	Company	0.02%	15,562	$81,000	—	31 Dec 2014	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	14,927	$78,000	—	31 Dec 2014	13F
Verition Fund Management LLC	13F	Company	0.02%	14,413	$75,000	—	31 Dec 2014	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.02%	13,186	$69,000	—	31 Dec 2014	13F
CITIGROUP INC	13F	Company	0.02%	11,624	$61,000	—	31 Dec 2014	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	10,897	$57,000	—	31 Dec 2014	13F
TFS CAPITAL LLC	13F	Company	0.02%	10,881	$57,000	—	31 Dec 2014	13F
UBS Group AG	13F	Company	0.01%	8,865	$46,000	—	31 Dec 2014	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	5,330	$28,000	—	31 Dec 2014	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	4,600	$24,058	—	31 Dec 2014	13F
BARCLAYS PLC	13F	Company	0.01%	3,700	$19,000	—	31 Dec 2014	13F
STANCORP INVESTMENT ADVISERS INC	13F	Company	0%	1,637	$9,000	—	31 Dec 2014	13F
US BANCORP \DE\	13F	Company	0%	1,500	$8,000	—	31 Dec 2014	13F
MSI Financial Services Inc	13F	Company	0%	1,000	$5,000	—	31 Dec 2014	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	931	$5,000	—	31 Dec 2014	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	521	$3,000	—	31 Dec 2014	13F
Creative Planning	13F	Company	0%	500	$3,000	—	31 Dec 2014	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	300	$2,000	—	31 Dec 2014	13F
WFG Advisors, LP	13F	Company	0%	200	$1,000	—	31 Dec 2014	13F

Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q1 2015

As of 31 Mar 2015, SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,615,535 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Pine River Capital Management L.P., FIL Ltd, BlackRock Fund Advisors, Zurcher Kantonalbank (Zurich Cantonalbank), DEUTSCHE BANK AG\, Invesco Ltd., and Eqis Capital Management, Inc.. This page lists 37 institutional shareholders reporting positions in this security for the Q1 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders

Q1 2015 holders

Holder diff

-5

Investor	Q4 2014 Shares	Q1 2015 Shares	Share Diff	Share Chg %	Q4 2014 Value $	Q1 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.